Greg Minzenmayer, chief operating officer at Glidewell Laboratories, has a career in the dental industry spanning over two decades, with a proven track record in sales, product management, marketing and business development. In 1994, he began at Den-Mat and in 1996 moved to Steri-Oss. Following the company’s acquisition by Nobel Biocare, Greg was promoted into the product development group and later to the position of director of marketing. He joined Glidewell in 2006 as director of implant business development, was appointed chief operating officer in 2010, and has been essential to the lab’s extensive growth in dental implants and prosthetics. Greg attended Chapman University in Orange, California. Contact him at firstname.lastname@example.org.